[The psoriasis--metabolic syndrome comorbidity, a complex multigenic disease]

Area of Science:

• Immunology
• Dermatology
• Endocrinology

Background:

• Psoriasis is a chronic inflammatory skin disease driven by specific immune cells and cytokines.
• It frequently co-occurs with comorbidities like metabolic syndrome, complicating patient management.
• Patient-centered care, complementing evidence-based medicine, is crucial for managing complex conditions.

Purpose of the Study:

• To explore the therapeutic potential of vitamin D in managing psoriasis.
• To investigate vitamin D's role in addressing psoriasis comorbidities, particularly metabolic syndrome.
• To assess the efficacy of oral vitamin D in mitigating cardiovascular risk in affected patients.

Main Methods:

• Review of existing literature on vitamin D's immunomodulatory effects.
• Analysis of studies examining vitamin D's impact on T helper cell activity.
• Examination of clinical data on vitamin D treatment for psoriasis and metabolic syndrome.

Main Results:

• Vitamin D demonstrates immunomodulatory properties beneficial for T helper cells.
• These effects translate to therapeutic advantages in psoriasis treatment.
• Vitamin D shows promise in managing metabolic syndrome and associated cardiovascular risks.

Conclusions:

• Vitamin D possesses significant therapeutic potential for psoriasis and its comorbidities.
• Oral vitamin D supplementation is a viable strategy to reduce cardiovascular risk.
• Integrating vitamin D into treatment plans supports a patient-centered approach for complex inflammatory conditions.